Atjaunināt sīkdatņu piekrišanu

Cardiology Pocketbook [Mīkstie vāki]

5.00/5 (4 ratings by Goodreads)
  • Formāts: Paperback / softback, 231 pages, Figures
  • Izdošanas datums: 01-Feb-2010
  • Izdevniecība: Borm Bruckmeier Publishing
  • ISBN-10: 1591032520
  • ISBN-13: 9781591032526
Citas grāmatas par šo tēmu:
  • Mīkstie vāki
  • Cena: 16,99 €
  • Grāmatu piegādes laiks ir 3-4 nedēļas, ja grāmata ir uz vietas izdevniecības noliktavā. Ja izdevējam nepieciešams publicēt jaunu tirāžu, grāmatas piegāde var aizkavēties.
  • Daudzums:
  • Ielikt grozā
  • Piegādes laiks - 4-6 nedēļas
  • Pievienot vēlmju sarakstam
Cardiology PocketbookPalielināt
  • Formāts: Paperback / softback, 231 pages, Figures
  • Izdošanas datums: 01-Feb-2010
  • Izdevniecība: Borm Bruckmeier Publishing
  • ISBN-10: 1591032520
  • ISBN-13: 9781591032526
Citas grāmatas par šo tēmu:
Permanent link: https://www.kriso.lv/db/9781591032526.html
1 Symptoms and Presentation
1.1 Chest Pain
9(3)
1.1.1 Cardiovascular
9(1)
1.1.2 Gastrointestinal
10(1)
1.1.3 Pulmonary
11(1)
1.1.4 Other
11(1)
1.2 Dyspnea
12(1)
1.2.1 Pulmonary Causes
12(1)
1.2.2 Cardiac Causes
12(1)
1.2.3 Other Causes
13(1)
1.3 Syncope
13(2)
1.3.1 Syncope Because of Arrhythmia
13(1)
1.3.2 Syncope Because of Ventricular Dysfunction
13(1)
1.3.3 Syncope Because of Cardiac Flow Obstruction
13(1)
1.3.4 Vasovagal Syncope
14(1)
1.3.5 Orthostatic Syncope
14(1)
1.3.6 Cerebrovascular Causes of Syncope
14(1)
1.3.7 Other Causes of Syncope
14(1)
1.4 Dizziness
15(2)
1.4.1 Peripheral Vestibular System Disorders
15(1)
1.4.2 Central Vestibular System Disorders
16(1)
1.4.3 Global Disturbances of CNS Function
16(1)
1.4.4 Other causes
16(1)
1.5 Palpitations
17(1)
1.6 Tachycardia
17(1)
1.7 Bradycardia
18(1)
1.8 Hypertension/Hypotension
18(1)
1.9 Cyanosis
18(1)
1.10 Edema
19(1)
1.11 Pericardial Effusion
19(1)
1.12 TIA
20(1)
1.13 Shock
20(1)
2 Diagnostic Testing
2.1 Murmurs and Heart Sounds
21(3)
2.1.1 Heart Sounds
21(1)
2.1.2 Murmurs
22(2)
2.2 Chest Radiography
24(2)
2.2.1 Standard Chest Radiograph: Posterior/Anterior and Laterial Views
24(1)
2.2.2 Typical Findings in Cardiac Conditions
25(1)
2.2.3 Contraindications
25(1)
2.3 ECG
26(6)
2.3.1 ECG Evaluation
26(1)
2.3.2 ECG Interpretation
27(1)
2.3.3 Normal ECG Findings
27(1)
2.3.4 Pathologic ECG Findings
28(3)
2.3.5 Myocardial Ischemia
31(1)
2.4 Exercise Stress Test
32(5)
2.4.1 Pharmacologic Stress Testing
36(1)
2.5 Pacemaker Checking
37(2)
2.6 Echocardiography
39(9)
2.7 Ankle-Brachial Index
48(1)
2.8 Duplex Sonography
49(3)
2.8.1 Duplex Sonography, Carotid
49(1)
2.8.2 Duplex Sonography, Peripheral Arteries
50(1)
2.8.3 Duplex Sonography, Venous
51(1)
2.9 Tilt Table Testing
52(1)
2.10 Single Photon Emission Computed Tomography
53(2)
2.11 Cardiac CT Angiography
55(4)
2.12 Cardiac Magnetic Resonance Imaging
59(4)
2.13 Cardiac Catheterization
63(10)
3 Cardiovascular Diseases
3.1 Ischemic Heart Disease: Stable Angina pectoris
73(9)
3.1.1 Clinical Assessment
73(1)
3.1.2 Grading of Angina Pectoris (CO Classification)
74(1)
3.1.3 Alternative Causes of Chest Pain
74(1)
3.1.4 Noninvasive Risk Stratification
75(1)
3.1.5 Initial Treatment for Patients with Angina
76(2)
3.1.5 Long-Term Therapy for Patients with Angina
78(4)
3.2 Acute Coronary Syndrome (ACS)
82(4)
3.2.1 Definition of ACS
82
3.2.2 Alternative Causes of Chest Pain
02(80)
3.2.3 ECU Diagnoses of ACS
82(1)
3.2.4 Clinical Suspicion of ACS
83(1)
3.2.5 Biochemical Cardiac Markers
84(1)
3.2.6 Cardiac Enzyme Kinetics
85(1)
3.2.7 Differential Diagnosis of High Truponin Level
85(1)
3.3 Unstable Angina/NSTEMI
86(5)
3.3.1 Principal Presentations of Unstable Angina
86(1)
3.3.2 UNNSTEMI: Shore-Term Risk of Death or Nonfatal MI
86(1)
3.3.3 TIMI Score for Patients with UNNSTEMI
87(1)
3.3.4 Selection of Initial Treatment Strategy
88(1)
3.3.5 Recommendations fur Anti-Ischemic Therapy
88(2)
3.3.5 Medications Used for Stabilized UAINSTEMI Patients
90(1)
3.4 STEMI
91(8)
3.4.1 Clinical Assessment
91(1)
3.4.2 Suspected STEMI
92(1)
3.4.3 Dosage of Fibrinolytic Agents
93(1)
3.4.4 Contraindications to Fibrinolysis
93(1)
3.4.5 Guidelines for Medical Management of STEMI(ACC/AHA)
94(2)
3.4.6 Management of Acute Pulmonary Edema or Cardiogenic Shock
96
3.4.7 Long-Term Therapy after ACS (UA/NSTEMI or STEMI)
67(32)
3.5 Microvascular Angiopathy
99(13)
3.5.1 Hypertension: General Data
99(7)
3.5.2 Hypertensive Crisis
106(1)
3.5.3 Hypertensive Heart Disease
107(2)
3.5.4 Diabetic Heart Disease
109(3)
3.6 Inflammatory Heart and Vascular Diseases
112(13)
3.6.1 Myocarditis
112(3)
3.6.2 Eralocarditis
115(3)
3.6.3 Pericarditis
118(3)
3.6.4 Vasculitis
121(4)
3.7 Diseases of Large Vessels
125(15)
3.7.1 Carotid Artery Stenosis
125(3)
3.7.2 Renal Artery Stenosis
128(3)
3.7.3 Aortic Dissection and Aneurysm
131(4)
3.7.4 Peripheral Arterial Disease
135(5)
3.8 Cardiomyopathies
140(16)
3.8.1 Dilated Cardiomyapathy
140(2)
3.8.2 Hypertraphic Cardiomyopathy (HCM)
142(3)
3.8.3 Restrictive Cardiomyopathy (RCM)
145(4)
3.8.4 Constrictive Pericarditis
149(4)
3.8.5 Takotsubo Cardiomyopathy (TCM)
153(3)
3.9 Arrhythmias
156(15)
3.9.1 Atrial Flutter/Fibrillation
156(5)
3.9.2 Ventricular Tachycardia
161(3)
3.9.3 Ventricular Fibrillation
164(3)
3.9.4 High Grade and Complete A-V Block
167(4)
3.10 Heart Failure
171(9)
3.10.1 General Information
171(1)
3.10.2 Neurohormonal Mechanisms of Heart Failure
171(1)
3.10.3 Causes of Nonischemic Cardiomyopathy
172(1)
3.10.4 Progression al Heart Failure
173(1)
3.10.5 New York Heart Association Classification of Heart Failure
174(1)
3.10.6 Assessment/Treatment of Acute Decompensated Heart Failure
174(1)
3.10.7 PRIDE Acute Congestive Heart Failure (CHF) Score
174(1)
3.10.8 Clinical Evaluation/Triage for Patients with Suspected Acute CHFI
175(1)
3.10.9 Initial Evaluation of Patients with Heart Failure
176(1)
3.10.10 Indications for Implantable Cardiac Defibrillator for Primary Prevention
176(2)
3.10.11 Indications for Cardiac Resynchronization Therapy (CRT)
178
3.10.12 Heart Failure with Preserved Left Ventricular Function
177(1)
3.10.13 Right Ventricular Failure
177(1)
3.10.14 Pharmacologic Therapy
178(2)
4 Preoperative Evaluation Prior to Noncardiac Surgery
4.1 Background
180(4)
4.1.1 Objective
180(1)
4.1.2 Clinical Presentation
180(1)
4.1.3 Assessment of Functional Capacity
181(1)
4.1.4 Physical Examination
181(1)
4.1.5 Clinical Predictors of Risk
181(1)
4.1.6 Type of Noncardiac Surgery
182(1)
4.1.7 Criteria for Estimating the Risk
182(2)
4.2 Diagnostic Testing
184(2)
4.2.1 General Information
184(1)
4.2.2 Laboratory Testing
184(1)
4.2.3 Exercise ECG Testing
184(1)
4.2.4 Echocardiogram
185(1)
4.2.5 Perfusion Nuclear Imaging and Stress Echocardiography
185(1)
4.2.6 Coronary Angiography Indications
186(1)
4.3 Therapy
186(5)
4.3.1 Critical Aortic Stenosis
186(1)
4.3.2 Mitral Stenosis
186(1)
4.3.3 Aortic/Mitral Regurgitation
186(1)
4.3.4 Prosthetic Valves
186(1)
4.3.5 Antithrombotic Therapy
187(1)
4.3.6 Arrhythmias
187(1)
4.3.7 Hypertension
187(1)
4.3.8 Cardiomyopathy
188(1)
4.3.9 Coronary Artery Disease
188(1)
4.3.10 Beta Bloekers
188(1)
4.3.11 Carotid Stenosis
188(1)
4.3.12 Perioperative Management
189(1)
4.3.13 Postoperative Management
189(1)
4.3.14 General Recommendations
189(1)
4.3.15 Cardiac Evaluation and Care: Algorithm for Noncarcliac Surgery
190(1)
5 Cardiovascular Drugs
5.1 Vasopressors
191(1)
5.2 Beta Blockers
192(2)
5.3 ACE Inhibitors
194(3)
5.3.1 ACE Inhibitors: Single Ingredient Drugs
194(2)
5.3.2 ACE Inhibitors: Combinations
196(1)
5.4 Angiotensin II Receptor Blockers
197(1)
5.4.1 Angiotensin II Receptor Blockers: Single Ingredient Drugs
197(1)
5.4.2 Angiotensin II Receptor Blockers: Combinations
198(1)
5.5 Renin Inhibitors
198(1)
5.5.1 Renin inhibitors: Single Ingredient Drugs
198(1)
5.5.2 Resin Inhibitors: Combinations
198(1)
5.6 Calcium Channel Blockers
199(2)
5.6.1 CCBs: Dihydropyridines
199(1)
5.6.2 CCBs: Non-dihydropyridines
200(1)
5.7 Adrenergic Inhibitors
201(1)
5.7.1 Central Acting Alpha Agonists
201(1)
5.7.2 Alpha-Adrenergic Blockers
201(1)
5.7.3 Peripheral Acting Adrcriergic Blockers
202(1)
5.8 Direct Vasodilators
202(2)
5.9 Pulmonary Arterial Antihypertensives
204(1)
5.10 Diuretics
205(3)
5.10.1 Thiazide Diuretics
205(1)
5.10.2 Loop Diuretics
206(1)
5.10.3 Potassium-sparing Diuretics
206(1)
5.10.4 Aldosterone Antagonists
207(1)
5.10.5 Potassium-sparing Diuretics: Combinations
207(1)
5.10.6 Diuretics: Carbonic Anhydrase Inhibitors
207(1)
5.11 Antihypertensive Combinations
208(1)
5.12 Nitrates
209(1)
5.72.1 Nitrates: Single Ingredient Drugs
209(1)
5.12.2 Nitrates: Combinations
210(1)
5.13 Other Antianginal Drugs
210(61)
5.14 Antiarrhythmics
271
5.15 Cardiac Glycosides
214(1)
5.16 Phosphodiesterase Inhibitors
215(1)
5.17 Antillpidemies
215(3)
5.17.1 Bile Acid Sequestrants
215(1)
5.17.2 Cholesterol Absorption Inhibitors
216(1)
5.17.3 HMG-CoA Reductase Inhibitors ("Statins")
216(1)
5.17.4 Statin Combinations
217(1)
5.18 NCEP ATP III Guidelines
218(2)
5.18.1 LDL: Goals
218(1)
5.18.2 Fibric Acids
218(1)
5.18.3 Nicotinic Acid, Others
219(1)
Links to guidelines 220(3)
Index 223